NPS PHARMACEUTICALS INC
S-3, EX-23.1, 2000-07-19
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NPS PHARMACEUTICALS INC, S-3, EX-5.1, 2000-07-19
Next: GOVERNMENT SECURITIES INC FD GNMA SER 1V DEFINED ASSET FDS, 485BPOS, 2000-07-19



<PAGE>

                                                                    EXHIBIT 23.1

              Consent of Independent Certified Public Accountants


The Board of Directors
NPS Pharmaceuticals, Inc.:

     We consent to the use of our report incorporated herein by reference and to
the reference to our firm under the heading "Experts" in the prospectus.


                                                  /s/ KPMG LLP

Salt Lake City, Utah
July 17, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission